An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspective-Reference-Cited by-同舟云学术

An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspective

Published:2020-06-10 Issue:13 Volume:21 Page:1565-1578
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Saisho Yoshifumi¹^ORCID

Affiliation:

1. Department of Internal Medicine, Keio University School of Medicine , Tokyo, Japan

Funder

Ministry of Education, Culture, Sports, Science, and Technology

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1776262

Reference128 articles.

1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

2. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

3. Incretin therapy for diabetes mellitus type 2

4. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

5. Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40)

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Herbal Remedies for Type 2 Diabetes Mellitus- An explicit Review;Current Drug Therapy;2024-08-06

2. The interaction between non-coding RNAs and SGLT2: A review;International Journal of Cardiology;2024-03

3. SGLT2 Inhibitors: Paradigm Shift from Diabetes Care to Metabolic Care—An Indian Perspective;Indian Journal of Endocrinology and Metabolism;2024-01

4. Higher systolic blood pressure is specifically associated with better islet beta-cell function in T2DM patients with high glycemic level;Cardiovascular Diabetology;2022-12-19

5. Clinical efficacy and safety of astragalus injection combined with ACEI/ARB in the treatment of diabetic kidney disease: Protocol for a systematic review and meta-analysis;Medicine;2022-12-09